TY  - JOUR
AU  - Marcellusi, A
AU  - Viti, R
AU  - Sciattella, P
AU  - Sarmati, L
AU  - Streinu-Cercel, A
AU  - Pana, A
AU  - Espin, J
AU  - Horcajada, J P
AU  - Favato, G
AU  - Andretta, D
AU  - Soro, M
AU  - Andreoni, M
AU  - Mennini, F S
PY  - 2019
DO  - 10.1080/14737167.2019.1569516
UR  - http://hdl.handle.net/10668/13504
T2  - Expert review of pharmacoeconomics & outcomes research
AB  - Background: The aim of this study was to develop a spending predictor model to evaluate the direct costs associated with the management of ABSSSIs from the National health-care provider's perspective of Italy, Romania, and Spain. Methodology: A...
LA  - en
KW  - ABSSSIs
KW  - Italy
KW  - Romania
KW  - Spain
KW  - dalbavancin
KW  - economic evaluation
KW  - Acute Disease
KW  - Anti-Bacterial Agents
KW  - Computer Simulation
KW  - Cost-Benefit Analysis
KW  - Decision Support Techniques
KW  - Hospitalization
KW  - Humans
KW  - Italy
KW  - Length of Stay
KW  - Models, Economic
KW  - Romania
KW  - Skin Diseases, Bacterial
KW  - Spain
KW  - Teicoplanin
TI  - Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries.
TY  - research article
VL  - 19
ER  -